News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
219 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17912)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (176)
2 (7)
3 (6)
4 (219)
5 (189)
6 (212)
7 (230)
8 (95)
9 (2)
10 (7)
11 (143)
12 (249)
13 (209)
14 (213)
15 (105)
16 (3)
17 (5)
18 (200)
19 (228)
20 (201)
21 (239)
22 (96)
23 (3)
24 (6)
25 (203)
26 (268)
27 (220)
28 (279)
29 (127)
30 (2)
31 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
Biophytis Announces Promising Full Results From the SARA-INT Phase 2b Trial of Sarconeos (BIO101) in Sarcopenia at the 11th Annual International Conference on Frailty and Sarcopenia Research (ICFSR) September 29 – October 2, 2021
Biophytis SA announces the full results from the SARA-INT Phase 2 trial of Sarconeos in Sarcopenia that have been presented at the International Conference on Frailty and Sarcopenia Research on September, 30th.
October 4, 2021
·
7 min read
Tissue Plasminogen Activator Market - North America has been showing considerable prospects in this market | Here’s Why
Advances in recombinant technology have enabled researchers to utilize the thrombolytic activity of tissue plasminogen activator in synthetic products.
October 4, 2021
·
5 min read
Spinal Cord Trauma Treatment Market: Increase in incidence of road accidents is expected to drive the market
Demand for spinal cord trauma treatment has increased due to advancements in the field of osteopathy. Spinal cord can be injured or damaged due to various reasons, including undue pressure and stress.
October 4, 2021
·
5 min read
Transdermal Drugs Market to Witness Exponential Growth during the Forecast Period
The technological advancements observed in the biopharmaceutical sector and the rising geriatric population numbers around the world are vital factors that will have a positive impact on the growth of the transdermal drugs market during the assessment period of 2021-2031.
October 4, 2021
·
6 min read
Policy
ENHERTU® Granted Breakthrough Therapy Designation in U.S. for Patients with HER2 Positive Metastatic Breast Cancer Treated with One or More Prior Anti-HER2-Based Regimens
The U.S. Food and Drug Administration has granted ENHERTU® Breakthrough Therapy Designation in the U.S. for the treatment of adult patients with unresectable or metastatic HER2 positive breast cancer who have received one or more prior anti-HER2-based regimens.
October 4, 2021
·
21 min read
Root Canal Sealer Market | Current Insight with Future Aspect Analysis
Root canal sealers are utilized to seal space between the dentinal divider and obturating center interface.
October 4, 2021
·
4 min read
Non-Insulin Therapies for Diabetes Market in 2021 - Detailed Analysis Report with Forecast
Non-insulin treatments are generally utilized in type 2 diabetes patients, where body either doesn’t deliver enough insulin or can’t successfully utilize the insulin it produces.
October 4, 2021
·
4 min read
CEA Antibodies Market: Rise in global cancer patient population to drive the market
Carcinoembryonic antigen (CEA) is a protein usually produced in developing fetus and disappears or is absent in adults. Production of abnormal amount of CEA protein could lead to cancer.
October 4, 2021
·
6 min read
Biotech Beach
ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
ViaDerma, Inc., is pleased to announce they are launching two new and improved formulas for its top selling product, Vitastem and Vitastem Ultra.
October 4, 2021
·
2 min read
Drug Development
Kintor Pharma Announces First Patient Dosing in Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients in US
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that on October 1 its phase III clinical trial of proxalutamide for the treatment of hospitalized COVID-19 patients has enrolled and dosed its first patient in the United States.
October 4, 2021
·
3 min read
Previous
16 of 22
Next